Lv7
4730 积分 2022-09-22 加入
Biparatopic targeting of IL-23 enables dual-epitope engagement and enhanced neutralization potency
1个月前
已完结
A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic‐related cytokine release syndrome
2个月前
已完结
Bispecific T-cell engager therapy for multiple myeloma
2个月前
已完结
Practical Management of Bispecific Antibodies in Multiple Myeloma
2个月前
已完结
Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments
2个月前
已完结
MM-906: First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results
3个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
3个月前
已完结
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma
3个月前
已完结
PEG-Free Monosialoganglioside Lipid Nanoparticles with Spleen-Selective mRNA Delivery for Cancer Immunotherapy
3个月前
已关闭
皖公网安备34019202002308
